Common Contracts
3 similar Development and Supply Agreement contracts by Zomedica Pharmaceuticals Corp.
Confidential Treatment has been requested as to certain portions of this document. Each such portion, which has been omitted herein and replaced with an asterisk [*], has been filed separately with the Securities and Exchange Commission.] CONFIDENTIAL...Development and Supply Agreement • May 5th, 2020 • New York
This Development and Supply Agreement (this “Agreement”), effective as of November 26, 2018 (the “Effective Date”) is entered into by and between Qorvo Biotechnologies, LLC having its principal place of business at 14505 21st Ave. N., Suite 212, Plymouth, MN 55447, USA (“Qorvo”), and Zomedica Pharmaceuticals Corp., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica”). Each of Qorvo and Zomedica may hereafter be referred to as a “Party” or collectively as the “Parties.”
DEVELOPMENT AND SUPPLY AGREEMENT Between QORVO BIOTECHNOLOGIES, LLC and ZOMEDICA PHARMACEUTICALS CORP. dated NOVEMBER 26, 2018Development and Supply Agreement • March 14th, 2019 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
This Development and Supply Agreement (this “Agreement”), effective as of November 26, 2018 (the “Effective Date”) is entered into by and between Qorvo Biotechnologies, LLC having its principal place of business at 14505 21st Ave. N., Suite 212, Plymouth, MN 55447, USA (“Qorvo”), and Zomedica Pharmaceuticals Corp., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica”). Each of Qorvo and Zomedica may hereafter be referred to as a “Party” or collectively as the “Parties.”
DEVELOPMENT AND SUPPLY AGREEMENT Between QORVO BIOTECHNOLOGIES, LLC and ZOMEDICA PHARMACEUTICALS CORP. dated NOVEMBER 26, 2018Development and Supply Agreement • February 26th, 2019 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
This Development and Supply Agreement (this “Agreement”), effective as of November 26, 2018 (the “Effective Date”) is entered into by and between Qorvo Biotechnologies, LLC having its principal place of business at 14505 21st Ave. N., Suite 212, Plymouth, MN 55447, USA (“Qorvo”), and Zomedica Pharmaceuticals Corp., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica”). Each of Qorvo and Zomedica may hereafter be referred to as a “Party” or collectively as the “Parties.”
